12 Mar, 2024 Life Sciences Regulation in the EU: Overview By Marco de Morpurgo Nicola Landolfi Nadia Feola Heidi Waem +1 more... Show less DLA Piper's Life Sciences Regulatory team, led by Marco de Morpurgo, recently produced a Q&A guide to life sciences regulation in the EU...
19 Oct, 2022 EU Pharma & Medical Device Regulation 2023 By Marco de Morpurgo Nicola Landolfi Our EU Life Sciences Regulatory team led by Marco de Morpurgo and Nicola Landolfi have produced a guide on EU Pharma & Medical Device...
17 May, 2021 Interactions with healthcare professionals – launch of the new DLA Piper interactive compliance site for pharmaceutical companies By Marco de Morpurgo Andrzej Balicki, Ph.D. Ethical relations with healthcare professionals are of vital importance for pharmaceutical companies. Cooperation with them results in a...
05 Jun, 2023 2023 Global M&A Intelligence Report – Life Sciences Supplement By Victoria Rhodes Robert Newman The DLA Piper Life Sciences sector team is delighted to announce the launch of our new 2023 Global M&A Intelligence Report – Life...
23 Apr, 2020 Clinical trials during the COVID-19 pandemic: A global guide By Dr Kokularajah Paheenthararajah After weeks of intensive collaboration and inspiring contributions from more than 100 Life Sciences enthusiasts across five continents,...
26 Jul, 2023 European Medicines Agency opens dialogue on use of AI in pharmaceutical life cycle By Danny Tobey Keo Shaw Marco de Morpurgo To open a dialogue with developers, academics, and regulators, the European Medicines Agency (EMA) recently published a draft Reflection...
23 Nov, 2020 Telehealth around the world: A global guide By Greg Bodulovic Marco de Morpurgo The COVID-19 pandemic has caused healthcare systems around the globe to rapidly, and in some cases, radically rethink the delivery of...
25 Jan, 2022 Update: DLA Piper Global COVID-19 Vaccine Guide for Employers By Marco de Morpurgo DLA Piper’s Life Sciences team has updated our recent vaccine guide for employers. The changes include significant updates to several...
05 Oct, 2021 Update: DLA Piper Global COVID-19 Vaccine Guide for Employers By Marco de Morpurgo DLA Piper’s Life Sciences team has updated our recent vaccine guide for employers. The changes include the additions of Sweden and...
25 May, 2021 Launch of DLA Piper Global COVID-19 Vaccine Guide for Employers By Pilar Menor Marco de Morpurgo As the scientific response to the COVID-19 pandemic develops, many employers are considering what their approach should be to the issues...
16 Mar, 2021 Wearable technologies: legal lifecycle of taking a new product to market By Marco de Morpurgo Wearable devices is a term used for electronic devices that can be worn on the body, either as an accessory like a watch or a pair of...
19 Feb, 2024 FDA’s new Quality Management System Regulation is here: Key takeaways for device companies in US, EU, and China By Bethany Hills Christopher Mikson Perham Gorji Jae Kim Adam Donat Marco de Morpurgo Ting Xiao +4 more... Show less On January 21, 2024, the FDA issued a final rule amending its Quality System (QS) regulations under 21 CFR Part 820, which addresses...
03 Jan, 2024 European Medicines Agency publishes five-year AI workplan By Coran Darling Keo Shaw Danny Tobey Marco de Morpurgo +1 more... Show less On December 18, 2023, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) published their 2023-2028...
03 Apr, 2020 European Commission proposes one-year postponement of MDR application date By Mark Franklin Marco de Morpurgo Paula Gonzalez de Castejón Llano-Ponte Nicola Landolfi +1 more... Show less Following an informal heads-up on 25 March 2020, today the European Commission adopted a proposed regulation to postpone by one year the...
26 May, 2023 EU Pharma Law Revision: First Reactions and Next Steps By Marco de Morpurgo Laetitia Mouton Mary Foord-Weston Exactly one month ago, on 26 April 2023, the European Commission (EC) adopted its long-awaited proposal for the revision of the EU...
20 Mar, 2023 Extended transition period gives medical device industry extra time to comply with EU MDR By Marco de Morpurgo Nicola Landolfi A much-awaited extension of the MDR transition period became effective today with the publication of Regulation (EU) 2023/607 in the...